Although the T3 treatment has appeared as a miracle drug at the beginning, it is not yet used as a standard medication and in some countries it is still considered experimental. The reason the T3 therapy is still unavailable in many countries is its potential side effects and the risk for some more sensitive patients such as women are. Caution is a necessary evil in these cases.

The primer concern of the scientists is that most hypothyroid patients are in fact women and the severe side-effects experienced from the T3 medication will affect more sides of their lives. The received treatments were recommended as safe and no additional information about possible risks of the therapy was given. Many women researchers see the negligence as a scarification of the women's health for the financial interest of the research companies.

Assembling to many other new discovered therapies, the ?miracle? medication using T3 has not yet been sufficiently tested and especially not on the most riskful categories represented by elder persons, women and minority groups. Further more, many women that could have been easily saved if treated properly, died from different heart diseases related to hypothyroidism as the possible connection between the two conditions was ignored.

The newest and most important question persisting is whether the T3 therapy has different effects upon women and men. Women in postmenopausal period are especially sensitive to the thyroid therapy as they have lost the estrogen protection and are more susceptible to heart diseases.

A small research on 33 patients around the age of 46 was made during a ten week treatment with T3 hormone. The primer tasks investigated were the long-term effects, the implications of therapy on patients of the age 65 and more, the effects on postmenopausal women with no hormonal substitute and the effect on those on hormone replacement. Further clauses of the research were the effects of the therapy on children, on pregnant and breastfeeding women, how T3 affects different races and ethnics, hoe the treatment can interfere with other medications and how it can affect associated diseases like cancer, diabetes or heart conditions.

Until all these questions don't get a certain answer, the T3 therapy remains an experiment and can only be used under the physician's observation. You should know not to use T3 unless it produces major benefits for your own pathology. You must be fully informed about the risks of this treatment.

Possible side-effects of the therapy are hyperthyroidism and depressions. All patients undergoing experimental medications must give their informed consent before starting the therapy.